explore -WSS

explore

author：hotspot 2025-09-27 23:01:40 - browse：361

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： WATCH: Why do fingernails fall off when they're damaged?

WSS

Special counsel alerts court to Trump’s social media post

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

The strategy behind pharma's lawsuits over drug pricing reform

Scientists find bacteria from stomach of ancient iceman

Eat, drink, but be wary — 4 foods that interact with medications

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

explore

explore

focus

Continuity nursing helped my family in our darkest PICU moments

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Bright Health sells Medicare Advantage business to Molina

New company forms to vet health AI models, root out weaknesses

Sports medicine is finally prioritizing gender equality

STAT's guide to the next generation of CAR

Trump demands the U.S. pay no more for drugs than other countries … again

New company forms to vet health AI models, root out weaknesses

At least 13 dead in Texas as scorching temps continue

The strategy behind pharma's lawsuits over drug pricing reform

explore

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Weight bias in eating disorder treatment complicated by new weight loss drugs

Special counsel alerts court to Trump’s social media post

New company forms to vet health AI models, root out weaknesses

Special counsel alerts court to Trump’s social media post

Donald Trump's relentless attacks on special counsel Jack Smith

focus

entertainment

hotspot

entertainment